IMRX
#3254
Immuneering Corporation - Class A Common Stock
5.0 2 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.65%
Changement Mensuel
+16.74%
Evolution sur 6 mois
+3.51%
Changement Annuel
-10.68%
Clôture Précédente
5.2 1
Open
5.0 3
Low
5.0 2
High
5.0 5
Volume
110
Financials
- Market Capitalization 324.78 M
- Employee 57
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.18
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3215 |  ABEO Abeona Therapeutics Inc. - Common Stock | 5.93 USD | -1.82% | -2.63% | -2.31% | -14.43% | 339.10 M USD | ||
| 3230 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.39 USD | -3.24% | +0.42% | +3.46% | +29.19% | 333.49 M USD | ||
| 3269 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.27 USD | -3.13% | -0.75% | +2.73% | -4.70% | 318.64 M USD | ||
| 3299 |  IRD Opus Genetics, Inc. - Common Stock | 3.73 USD | -3.12% | -12.44% | +8.12% | +0.27% | 310.32 M USD |